Literature DB >> 17402444

Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders.

M E McCue1, W P Ribeiro, S J Valberg.   

Abstract

REASONS FOR PERFORMING STUDY: Controversy exists as to the prevalence of polysaccharide storage myopathy (PSSM) in breeds of horses and its impact on performance.
OBJECTIVES: To determine 1) the prevalence of PSSM in horses that presented with a neuromuscular disorder, as well as breed, sex and age distributions and clinical signs 2) effect of diagnostic criteria on prevalence, breed distribution and age of horses diagnosed with PSSM.
METHODS: Fresh frozen biopsies (n = 1426) submitted to the Neuromuscular Diagnostic Laboratory at the University of Minnesota were searched to identify horses diagnosed with PSSM. Horses with and without histological evidence of PSSM were compared. Biopsies were classified as Grade 1, containing aggregates of granular glycogen or Grade 2, containing periodic acid Schiff's (PAS) positive inclusions, traditionally resistant to amylase digestion.
RESULTS: Horses (n = 572 : 40.1%) were identified with PSSM, of which 62.9% were Quarter Horse related breeds (QHR), 11.5% Draught breeds (DB) and 8.9% Warmblood breeds (WB). Exertional rhabdomyolysis was more prevalent in QHR than DB and WB, whereas QHR were less likely to have muscle atrophy compared to DB. QHR were less likely to have gait abnormalities than DB and WB. The highest within breed prevalence of PSSM was in DB at 63/116, WB 58/111 and QHR 360/753. Exclusion of Grade 1 criteria decreased the overall prevalence of PSSM to 21.7% of biopsy submissions, and decreased the within breed prevalence in each breed category. The within breed prevalence decreased most substantially in the breeds less commonly diagnosed with PSSM, Thoroughbreds (4.5%) and Arabians (2.5%).
CONCLUSION: PSSM is a common cause of neuromuscular disease in QHR, DB and WB related breeds. Inclusion of granular glycogen as the sole diagnostic criterion may increase the sensitivity of this diagnostic test, but conversely it may decrease the specificity of the diagnosis resulting in the inclusion of horses of Thoroughbred, Arabian and other breeds. POTENTIAL RELEVANCE: PSSM is an important differential diagnosis for QHR, WB and DB presenting with signs of rhabdomyolysis, gait abnormalities and muscle atrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17402444     DOI: 10.1111/j.2042-3306.2006.tb05565.x

Source DB:  PubMed          Journal:  Equine Vet J Suppl


  7 in total

1.  Genetic mapping of recurrent exertional rhabdomyolysis in a population of North American Thoroughbreds.

Authors:  K L Fritz; M E McCue; S J Valberg; A K Rendahl; J R Mickelson
Journal:  Anim Genet       Date:  2012-03-23       Impact factor: 3.169

2.  Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions.

Authors:  Eric Barrey; Elodie Mucher; Nicolas Jeansoule; Thibaut Larcher; Lydie Guigand; Bérénice Herszberg; Stéphane Chaffaux; Gérard Guérin; Xavier Mata; Philippe Benech; Marielle Canale; Olivier Alibert; Péguy Maltere; Xavier Gidrol
Journal:  BMC Vet Res       Date:  2009-08-07       Impact factor: 2.741

3.  Epidemiology of exertional rhabdomyolysis susceptibility in standardbred horses reveals associated risk factors and underlying enhanced performance.

Authors:  Cajsa M Isgren; Melissa M Upjohn; Marta Fernandez-Fuente; Claire Massey; Geoff Pollott; Kristien L P Verheyen; Richard J Piercy
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

4.  Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis.

Authors:  Molly E McCue; Stephanie J Valberg; Michael B Miller; Claire Wade; Salvatore DiMauro; Hasan O Akman; James R Mickelson
Journal:  Genomics       Date:  2008-03-20       Impact factor: 5.736

5.  Suspected myofibrillar myopathy in Arabian horses with a history of exertional rhabdomyolysis.

Authors:  S J Valberg; E C McKenzie; L V Eyrich; J Shivers; N E Barnes; C J Finno
Journal:  Equine Vet J       Date:  2015-09-07       Impact factor: 2.888

6.  Prevalence of the Mutations Responsible for Glanzmann Thrombasthenia in Horses in Brazil.

Authors:  Raíssa O Leite; Júlia F Ferreira; César E T Araújo; Diego J Z Delfiol; Regina K Takahira; Alexandre S Borges; Jose P Oliveira-Filho
Journal:  Animals (Basel)       Date:  2019-11-13       Impact factor: 2.752

7.  Altered mitochondrial oxidative phosphorylation capacity in horses suffering from polysaccharide storage myopathy.

Authors:  Irene Tosi; Tatiana Art; Dominique Cassart; Frédéric Farnir; Justine Ceusters; Didier Serteyn; Hélène Lemieux; Dominique-Marie Votion
Journal:  J Bioenerg Biomembr       Date:  2018-08-24       Impact factor: 2.945

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.